BARD1: Options for Managing Cancer Risk
Risk Management for People with Inherited Mutations
People with mutations have options for managing their increased cancer risk. Experts at the National Comprehensive Cancer Network (NCCN) created guidelines for people with a mutation to manage their cancer risk.
We recommend that you speak with a genetics expert who can look at your personal and family history of cancer and can help you decide on a plan to manage your risk. You can learn more about risk management options in our section on Screening and Risk Reduction by Cancer Type.
Beginning Age |
Recommendation |
Additional Information |
25 |
Learn to be aware of changes in your breasts. |
Based on NCCN guidelines for women of average risk. |
25 |
Breast exam by doctor every 1-3 years. |
Based on NCCN guidelines for women of average risk. |
40 (or earlier based on family history of breast cancer) |
Have a discussion with your doctor about the benefits, risks and costs of yearly breast MRI with and without contrast. |
|
40 (or earlier based on family history of breast cancer) |
Yearly mammogram. |
|
No set age |
Have a discussion with your doctor about the risks and costs of medications to lower the risk for breast cancer. |
Tamoxifen or other estrogen-blocking drugs may lower breast cancer risk. Medications or vaccines are being studied in clinical trials. |
No set age |
More research is needed to show whether people with inherited BARD1 mutations benefit from risk-reducing mastectomy. Discuss with your doctor about the option of risk-reducing mastectomy based on your personal and family history of cancer. |
Risk-reducing mastectomy lowers breast cancer risk by 90%, but has not been shown to improve survival. Even after double mastectomy, some breast tissue, and therefore cancer risk remains. |
Source: NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, Prostate, vs. 3, 2025. |
||
Other cancers
There has not been enough research to show a benefit from screening and prevention for other cancers in people who have a mutation. For this reason, experts recommend managing these risks based on your family history. Cancer screening and prevention research studies may be available.